Interestingly, the mean serum MCP-1 levels are 20–40% higher in T1D patients with most diabetic complications including hypertension, CAD, nephropathy, retinopathy, photocoagulation, blindness, dyslipidemia, amputation, and peripheral neuropathy. This evidence concerns the gene CCL2 and blindness (disorder).